SHYAM PATEL: Open Payments
NPI 1871974709 · WHITING, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 35 payments from 8 companies in 2025. Trend: 2023 $229 · 2024 $305 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $210 |
| Amgen Inc. | 19 | $164 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: BREZTRI, OTEZLA, REPATHA, AIRSUPRA, ZORYVE, Cologuard Collection Kit, TRELEGY ELLIPTA, GVOKE HYPOPEN.
Industry payments across IN — which companies pay providers there.
